Applied Clinical Trials-12-01-2016

Comparing mean vs. median to uncover the full data picture of site-level performance.

With a new administration in Washington, sponsors and regulators are weighing several initiatives that promise to reshape clinical research policies.

The Council adopts revision encouraging sponsors to implement improved oversight and management of clinical trials.

Survey collects thoughts from industry professionals on the current and future impact of big data in clinical trials.

With bidding starting to intensify among member states, several factors will determine the EMA’s next home.

For those still waiting, the time is now to get compliant on FDA's new data submission requirement.

New study finds that the long-strained relationship between sites and institutional review boards may finally be improving.

Assessing practices and inefficiencies with site selection, study start-up, and site activation.

How one large academic trial adopted a coordinating center model-helping drive early-model RBM gains

Q&A looks at the growing use of unstructured data in drug development and the evolving role of the clinical data manager amid the advent of real-world data as a research aid.

In its first published update since 2011, the CDISC Glossary Project Team has updated this resource, which includes hundreds of definitions for key terminology related to clinical research.

Click the title above to open the Applied Clinical Trials December 2016/January 2017 issue in an interactive PDF format.

Examining interventional vs. non-interventional clinical study classification in the EU.